Free Trial

Jasper Therapeutics (JSPR) Institutional Ownership

→ [URGENT] DO NOT Touch These AI Stocks! (From Weiss Ratings) (Ad)
Free JSPR Stock Alerts
$21.19
-1.58 (-6.94%)
(As of 05/8/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media

Institutional Ownership Changes (13F Filings) for Jasper Therapeutics (NASDAQ:JSPR)

Current
Institutional Ownership
Percentage
79.85%
Number of
Institutional Buyers
(last 12 months)
17
Total
Institutional Inflows
(last 12 months)
$374.85M
Number of
Institutional Sellers
(last 12 months)
3
Total
Institutional Outflows
(last 12 months)
$227.90M
Get JSPR Insider Trade Alerts

Want to know when executives and insiders are buying or selling Jasper Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

JSPR Institutional Buying and Selling by Quarter

Jasper Therapeutics Major Shareholders & Ownership History

Export to Excel
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/8/2024Russell Investments Group Ltd.79,811$2.34M0.0%N/A0.530%
5/7/2024 Concurrent Investment Advisors LLC20,409$599K0.0%N/A0.136%
5/3/2024 Carlyle Group Inc.1,066,189$31.30M2.0%-87.8%7.080%
3/18/2024Kingdon Capital Management L.L.C.3,540,000$2.79M0.3%+16.4%31.720%
2/15/2024Opaleye Management Inc.3,985,340$3.14M0.8%N/A35.717%
2/7/2024Ieq Capital LLC54,500$43K0.0%N/A0.488%
2/7/2024Monaco Asset Management SAM249,563$197K0.1%N/A2.236%
2/5/2024Fernwood Investment Management LLC494,706$390K0.1%+8.8%4.433%
11/13/2023Mariner LLC652,749$457K0.0%-8.7%0.589%
11/9/2023 Cowen AND Company LLC200,393$140K0.0%N/A0.181%
11/8/2023Forefront Analytics LLC110,792$78K0.0%+59.7%0.100%
10/30/2023 Summit Trail Advisors LLC65,000$46K0.0%N/A0.059%
8/15/2023Sphera Funds Management LTD.4,274,008$5.86M0.9%+5.7%3.874%
8/14/2023Jefferies Financial Group Inc.489,884$671K0.0%N/A0.444%
6/1/2023Prelude Capital Management LLC54,500$99K0.0%N/A0.049%
5/16/2023Ally Bridge Group NY LLC2,517,232$4.56M6.0%N/A2.301%
5/16/2023BVF Inc. IL9,900,000$17.92M0.7%N/A9.051%
5/15/2023Affinity Asset Advisors LLC476,948$863K0.3%N/A0.436%
5/15/2023Kingdon Capital Management L.L.C.3,040,000$5.50M1.0%+463.0%2.779%
5/15/2023RTW Investments LP2,329,809$4.22M0.1%N/A2.130%
5/12/2023Forefront Analytics LLC30,290$55K0.0%-73.4%0.028%
5/5/2023 Carlyle Group Inc.8,761,891$15.77M0.5%N/A8.011%
5/3/2023Jump Financial LLC33,074$60K0.0%N/A0.030%
4/25/2023Qiming U.S. Ventures Management LLC8,519,648$15.42M18.7%+45.6%7.789%
2/13/2023Forefront Analytics LLC114,000$55K0.0%-4.8%0.300%
2/7/2023Fernwood Investment Management LLC454,706$220K0.1%+53.1%1.197%
11/14/2022Forefront Analytics LLC119,800$94K0.1%+246.0%0.327%
11/9/2022Fernwood Investment Management LLC297,080$234K0.1%N/A0.810%
5/10/2022Sectoral Asset Management Inc.675,000$2.40M0.4%N/A1.782%
5/9/2022Forefront Analytics LLC32,550$118K0.0%N/A0.086%
4/27/2022Vahanian & Associates Financial Planning Inc.10,000$36K0.1%-60.0%0.026%
2/15/2022Kingdon Capital Management L.L.C.540,000$4.24M0.5%N/A1.427%
2/2/2022Grace Capital218,110$1.71M1.0%N/A0.576%
1/28/2022Vahanian & Associates Financial Planning Inc.25,000$196K0.2%N/A0.066%
11/16/2021Citadel Advisors LLC3,005,035$29.22M0.0%N/A8.228%
11/15/2021Tudor Investment Corp Et Al20,000$205K0.0%N/A0.055%
11/15/2021Abingworth LLP5,628,558$58.03M13.2%N/A15.412%
(Data available from 1/1/2016 forward)

JSPR Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of JSPR shares?

During the previous two years, 22 institutional investors and hedge funds held shares of Jasper Therapeutics. The most heavily invested institutionals were Carlyle Group Inc. ($31.30M), BVF Inc. IL ($17.92M), Qiming U.S. Ventures Management LLC ($15.42M), Sphera Funds Management LTD. ($5.86M), Ally Bridge Group NY LLC ($4.56M), RTW Investments LP ($4.22M), and Opaleye Management Inc. ($3.14M).Learn more on JSPR's institutional investors.

What percentage of Jasper Therapeutics stock is owned by institutional investors?

79.85% of Jasper Therapeutics stock is owned by institutional investors. Learn more on JSPR's institutional investor holdings.

Which institutional investors have been buying Jasper Therapeutics stock?

Of the 21 institutional investors that purchased Jasper Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BVF Inc. IL ($9.90M), Carlyle Group Inc. ($8.76M), Opaleye Management Inc. ($3.99M), Kingdon Capital Management L.L.C. ($3M), Qiming U.S. Ventures Management LLC ($2.67M), Ally Bridge Group NY LLC ($2.52M), and RTW Investments LP ($2.33M).

How much institutional buying is happening at Jasper Therapeutics?

Institutional investors have bought a total of 36,443,876 shares in the last 24 months. This purchase volume represents approximately $611.20M in transactions.

Which Jasper Therapeutics major shareholders have been selling company stock?

The following institutional investors have sold Jasper Therapeutics stock in the last 24 months: Carlyle Group Inc. ($7.70M), Forefront Analytics LLC ($89.51K), and Mariner LLC ($62.25K).

How much institutional selling is happening at Jasper Therapeutics?

Institutional investors have sold a total of 7,847,459 shares in the last 24 months. This volume of shares sold represents approximately $227.92M in transactions.


Related Companies:
This page (NASDAQ:JSPR) was last updated on 5/9/2024 by MarketBeat.com Staff

From Our Partners
Tech GIANT’s Plans to Revolutionize Crypto…
Crypto 101 Media
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
Dems have chosen Biden replacement?
Paradigm Press
The A.I. story nobody is telling you (Read ASAP)
TradeSmith
How Biden has already won 2024
Porter & Company
The “Next Bitcoin”? 10 CENT Crypto Set to Explode
True Market Insiders
“Crash Insurance” For Your Retirement
Unstoppable Prosperity
The #1 Crypto for AI
Weiss Ratings